Published in Drug Alcohol Depend on November 15, 2006
Overdose prevention and naloxone prescription for opioid users in San Francisco. J Urban Health (2010) 2.41
Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007. PLoS One (2013) 1.61
Overdose prevention for injection drug users: lessons learned from naloxone training and distribution programs in New York City. Harm Reduct J (2007) 1.34
Can abuse deterrent formulations make a difference? Expectation and speculation. Harm Reduct J (2009) 1.21
HIV infection and risk of overdose: a systematic review and meta-analysis. AIDS (2012) 1.18
Factors associated with history of non-fatal overdose among young nonmedical users of prescription drugs. Drug Alcohol Depend (2012) 1.16
Individual and network factors associated with non-fatal overdose among rural Appalachian drug users. Drug Alcohol Depend (2010) 1.15
Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature. Am J Public Health (2015) 0.99
Social and structural aspects of the overdose risk environment in St. Petersburg, Russia. Int J Drug Policy (2008) 0.94
Law enforcement attitudes toward overdose prevention and response. Drug Alcohol Depend (2013) 0.93
The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs. Drug Alcohol Depend (2015) 0.90
"I felt like a superhero": the experience of responding to drug overdose among individuals trained in overdose prevention. Int J Drug Policy (2013) 0.87
Correlates and contexts of US injection drug initiation among undocumented Mexican migrant men who were deported from the United States. AIDS Behav (2012) 0.85
Acceptability of a safer injection facility among injection drug users in San Francisco. Drug Alcohol Depend (2010) 0.83
Correlates of overdose risk perception among illicit opioid users. Drug Alcohol Depend (2015) 0.81
Drug use patterns predict risk of non-fatal overdose among street-involved youth in a Canadian setting. Drug Alcohol Depend (2015) 0.81
Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: Identifying opportunities for intervention. Drug Alcohol Depend (2015) 0.80
Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically. Addict Behav (2017) 0.79
Personal social network factors associated with overdose prevention training participation. Subst Use Misuse (2012) 0.77
Characteristics of Homeless Adults Who Died of Drug Overdose: A Retrospective Record Review. J Health Care Poor Underserved (2016) 0.75
Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study. Harm Reduct J (2017) 0.75
Impact of incarceration experiences on reported HIV status and associated risk behaviours and disease comorbidities. Eur J Public Health (2015) 0.75
Cross-sectional association between ZIP code-level gentrification and homelessness among a large community-based sample of people who inject drugs in 19 US cities. BMJ Open (2017) 0.75
Mortality from overdose among injecting drug users recently released from prison: database linkage study. BMJ (1998) 5.05
Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. Addiction (2003) 4.25
Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. Addiction (1999) 4.04
Fatal heroin 'overdose': a review. Addiction (1996) 3.70
Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. Addiction (1994) 3.47
Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999. Am J Public Health (2001) 3.43
Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001. AIDS (2005) 2.91
Prevention of spread of hepatitis C. Hepatology (2002) 2.90
Impact of HIV infection on mortality in a cohort of injection drug users. J Acquir Immune Defic Syndr (2001) 2.80
Factors associated with adolescent initiation of injection drug use. Public Health Rep (2001) 2.73
Self-reported overdose among injecting drug users in London: extent and nature of the problem. Addiction (1999) 2.72
Acute heroin overdose. Ann Intern Med (1999) 2.64
Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ (1996) 2.50
Heroin overdose: causes and consequences. Addiction (2001) 2.23
Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose. Addiction (1996) 2.20
Mortality among injecting drug users: a critical reappraisal. J Epidemiol Community Health (1993) 2.17
Strategies for preventing heroin overdose. BMJ (2003) 2.14
Heroin-related deaths in New South Wales, Australia, 1992-1996. Drug Alcohol Depend (2000) 2.07
Fatal heroin-related overdose in San Francisco, 1997-2000: a case for targeted intervention. J Urban Health (2003) 1.97
Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area. J Urban Health (2003) 1.96
Harm minimisation for drug misusers. BMJ (1992) 1.91
Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J Acquir Immune Defic Syndr (2000) 1.87
Risk factors for overdose mortality: a case-control study within a cohort of intravenous drug users. Int J Epidemiol (1993) 1.83
The first hit: circumstances surrounding initiation into injecting. Addiction (1996) 1.80
The consistency of self-reported HIV risk behavior among injection drug users. Am J Public Health (1994) 1.78
Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. Am J Epidemiol (1994) 1.77
Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions. Addiction (1998) 1.75
Witnessing heroin-related overdoses: the experiences of young injectors in San Francisco. Addiction (2002) 1.67
Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. Eur J Emerg Med (2004) 1.63
Patterns of presentation in heroin overdose resulting in pulmonary edema. Am J Emerg Med (2003) 1.49
Case-reporting of acute hepatitis B and C among injection drug users. J Urban Health (2002) 1.40
Fatal heroin overdoses resulting from non-injecting routes of administration, NSW, Australia, 1992-1996. Addiction (2000) 1.40
Racial/ethnic disparities in overdose mortality trends in New York City, 1990-1998. J Urban Health (2003) 1.31
Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City. J Urban Health (2003) 1.17
Transitions between routes of heroin administration: a study of Caucasian and Indochinese heroin users in south-western Sydney, Australia. Addiction (1999) 1.15
Heroin snorters versus injectors: comparison on drug use and treatment outcome in age-matched samples. Drug Alcohol Depend (1998) 0.89
Relationship between prescribing and risk of opiate overdose among drug users in and out of maintenance treatment. Eur Addict Res (2004) 0.88
Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence. Drug Alcohol Rev (2004) 0.87
Causes of death in hospitalized intravenous drug abusers. J Forensic Sci (1990) 0.85
Pre-AIDS deaths in HIV infection related to intravenous drug use. QJM (1997) 0.79
Detection of levamisole exposure in cocaine users by liquid chromatography-tandem mass spectrometry. J Anal Toxicol (2011) 1.21
Drug use, street survival, and risk behaviors among street children in Lahore, Pakistan. J Urban Health (2005) 1.18
Duloxetine and pregnancy outcomes: safety surveillance findings. Int J Med Sci (2013) 0.81